By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Percorso Life Sciences announced an agreement today to commercialize Generation Biotech's SNPSeq products and help develop its business.

Generation Biotech, based in Lawrenceville, NJ., develops tools for DNA analysis. According to a statement, its proprietary bead-based haplotype- and region-specific extraction technology allows for the sequence-specific isolation of DNA segments.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.